Seeking Alpha
 

Smith & Wesson Holding Corporation (SWHC)

- NASDAQ
  • Mar. 4, 2014, 5:48 PM
    • Top gainers, as of 5:15 p.m.: BV +11.1%. SWHC +8.1%. FCEL +5.5%. AVAV +4.9%. ARWR +3.6%.
    • Top losers, as of 5:15 p.m.: RAS -7.2%. CHEF -5.3%. BOBE -4.8%. FAC -4.6%. NUS -3.7%.
    | Comment!
  • Mar. 4, 2014, 4:22 PM
    • Smith & Wesson (SWHC) trades higher in post-close action after the companye bests the FQ3 profit estimate of analysts.
    • The company saw its gross profit margin rate rise 360 bps to 40.2% on a favorable product mix and reduced promotions.
    • FY14 revenue guidance is raised to $615M-$620M and the S&W sees EPS falling in a range of $1.39-$1.42.
    • SWHVC +7.1% AH
    | 4 Comments
  • Dec. 11, 2013, 10:02 AM
    • Smith & Wesson (SWHC +5%) trades higher following its FQ2 report and early look at FQ3 projections.
    • Execs with the company say they expected the big drop in November for NCIS background checks, a trend they see continuing through May of next year. They note the upcoming comparables run up against an enormous period of demand and they still see industry trends as positive.
    • Related stocks RGR, CAB.
    • Earnings call transcript
    | 2 Comments
  • Dec. 11, 2013, 9:11 AM
    | Comment!
  • Dec. 10, 2013, 5:42 PM
    • After-hours Top Gainers, as of 5:15 p.m.: VIMC +22.2%. SNI +12.9%. NRF +9.8%. SWHC +6.4%. BKS +5.1%.
    • After-hours Top Losers, as of 5.15 p.m.: AVNR -14.9%. MNKD -8.2%. LH -7.1%. AWAY -4.7%. NOG -3.9%.
    | Comment!
  • Dec. 10, 2013, 4:39 PM
    • Smith & Wesson (SWHC) shares jump 5.8% after the company cleaned out expectations in FQ2 and issued higher-than-expected FQ3 guidance.
    • Net sales of $139.3M were up 2% Y/Y; excluding Walther products (under a distribution agreement that ended in April), revenue grew 9.2% Y/Y, driven by a 27.4% Y/Y spike in handgun sales.
    • Gross margin represented a 510bp expansion to 41.6%, building on the trend in FQ1. The company cited favorable product mix, absorption, and manufacturing efficiencies, as well as absence of lower-margin Walther sales.
    • Opex jumped to 20.9% of sales, or $29.2M, from 16% of sales, or $21.8M, in FQ2 2012; excluding one-time ERP system expenses, opex would have come in at 18.2% of sales, or $25.3M.
    • Income from continuing operations was $17.1M ($0.28/share) vs. $16.4M ($0.24/share) in Q2 2012.
    • Management sees revenue in FQ3 of $140M-$145M (well above analyst consensus of $137.4M) and EPS of $0.28-$0.30 (vs. $0.27). It reiterates FY2014 guidance for sales of $610M-$620M (vs. $617M) and EPS of $1.30-$1.35 (vs. $1.32).
    • Conference call at 5pm ET, PR
    | 4 Comments
  • Oct. 8, 2013, 10:03 AM
    • The Taser (TASR +5.5%) price cut is not as bad as it seems, says JPMorgan's Paul Coster, who took the time to listen on the company conference call.
    • It's more a debundling of its Axon/Evidence.com service as total solution pricing has not changed - the company now charges for the first year of evidence.com storage and license fees. The new strategy is intended to eliminate customized sales contracts, thus accelerating the sales cycle.
    • Coster ups his price target to $13 from $12, but keeps the stock rated a Hold.
    • Related: RGR +1.4%, SWHC +1.1%.
    • Previous: The price cut story.
    | Comment!
  • Sep. 17, 2013, 2:51 PM
    • Sturm Ruger (RGR +2.4%), Cabela's (CAB +1.5%), and Smith & Wesson (SWHC +2.7%) trade higher after the stocks fell back in response to a mass shooting at the Washington D.C. Navy Yard yesterday.
    • Some early reaction to the tragedy is focused on the suspect's history of mental illness, although calls for stricter gun control laws are also part of the debate.
    • A broader theme in the weapons manufacturing sector is the trend toward slowing demand. Earlier this month, Smith & Wesson issued guidance for Q3 revenue which fell below the consensus estimate of analysts.
    | 11 Comments
  • Sep. 6, 2013, 12:45 PM
    | Comment!
  • Sep. 6, 2013, 11:26 AM
    • Dougherty is out defending Buy-rated Smith & Wesson (SWHC -8.4%) which is in the midst of a post-earnings swoon thanks to what many are viewing as disappointing guidance.
    • "The way we see it, handgun ownership and sport shooting are growing in popularity in accordance with demographic trends," analyst Andrea James says.
    • "Any stock weakness tied to the Q2 guide should be treated as an opportunity," she concludes.
    • Price target is $14.
    | 3 Comments
  • Sep. 6, 2013, 9:10 AM
    | Comment!
  • Sep. 5, 2013, 5:39 PM
    • After-hours top gainers, as of 5:15 p.m.: ZQK +13.4%. BLOX +13.2%. OFG +5.9%. AMBA +5.2%. TKR +5.1%.
    • After-hours top losers: NES -14.7%. ICH -8.4%. SWHC -5.0%. DRD -4.6%. BPL -3.7%.
    | Comment!
  • Sep. 5, 2013, 4:12 PM
    • Smith & Wesson (SWHC): FQ1 EPS of $0.40beats by $0.04.
    • Revenue of $171.0M (+25.8% Y/Y) beats by $5.98M. Shares -4.18% AH. (PR)
    | 8 Comments
  • Aug. 5, 2013, 5:31 PM
    | 5 Comments
  • Jul. 10, 2013, 6:43 PM
    Smith & Wesson (SWHC) increases the price of its previously announced tender offer from $10.00 per share to $11.00 per share. On June 13, its Board of Directors approved the repurchase of up to $100M of outstanding stock, including the cash repurchase of up to $75M of common stock by way of a fixed-price issuer tender offer. Shares +1.7% AH.
    | 6 Comments
  • Jul. 10, 2013, 3:51 PM
    Smith & Wesson (SWHC +0.8%) gets whipsawed on heavy volume in afternoon trading on reports of a $230M contract win from the U.S. Army that appears to be erroneous. An SWHC company spokesperson says that the contract award was for Smith & Wesson Security Solutions, which is a separate, stand-alone company.
    | Comment!
SWHC vs. ETF Alternatives
Company Description
Smith & Wesson Holding Corp manufactures firearms. It manufactures handguns, modern sporting rifles, hunting rifles, black powder firearms, handcuffs, and firearm-related products and accessories.